![Grant Bogle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Grant Bogle
Director/Board Member at
NUVALENT, INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Grant C.
Bogle currently works at Gladius Therapeutics, Inc., as Director, Nuvalent, Inc., as Independent Director from 2024, Myrobalan Therapeutics, Inc., as Director, and American School for the Deaf, as Director.
Mr. Bogle also formerly worked at Epizyme, Inc., as President, Chief Executive Officer, CFO & Director from 2021 to 2022, EIDP, Inc., as Principal, Millennium Pharmaceuticals, Inc., as Senior Vice President-Sales & Marketing, US Oncology, Inc., as EVP-Strategy & Emerging Businesses from 2010 to 2011, Roche Pharmaceuticals, Inc., as Principal, US Oncology Holdings, Inc., as Executive VP-Integrated Oncology Solutions, Tesaro, Inc., as Chief Commercial Officer & Senior Vice President from 2015 to 2019, Abbott India Ltd., as Principal, American Hospital Supply Corp., as Principal, and McKesson Specialty Health, Inc., as Senior VP-Pharmaceutical & Biotech Solutions.
Mr. Bogle received his Masters Business Admin degree from The Trustees of Columbia University in The City of New York and undergraduate degree from Dartmouth College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-15 | 9,291 ( 0.01% ) | 1 M $ | 2026-05-30 |
Grant Bogle active positions
| Companies | Position | Start |
|---|---|---|
| NUVALENT, INC. | Director/Board Member | 2024-12-08 |
Gladius Therapeutics, Inc.
 Gladius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Director/Board Member | - |
Myrobalan Therapeutics, Inc.
 Myrobalan Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech firm that develops therapeutic solutions for central nervous system disorders | Director/Board Member | - |
American School for the Deaf
 American School for the Deaf Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Former positions of Grant Bogle
| Companies | Position | End |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 2019-01-21 |
| EPIZYME, INC. | Chief Executive Officer | - |
McKesson Specialty Health, Inc.
 McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
American Hospital Supply Corp.
 American Hospital Supply Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells lines of medical care products | Corporate Officer/Principal | - |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company | Corporate Officer/Principal | - |
Training of Grant Bogle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
US Oncology, Inc.
 US Oncology, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
US Oncology Holdings, Inc.
US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company | Health Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott India Ltd.
 Abbott India Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, diagnostic, nutritional and hospital products | Health Technology |
American Hospital Supply Corp.
American Hospital Supply Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells lines of medical care products | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
American School for the Deaf
American School for the Deaf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McKesson Specialty Health, Inc.
McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Gladius Therapeutics, Inc.
Gladius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Myrobalan Therapeutics, Inc.
Myrobalan Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech firm that develops therapeutic solutions for central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Grant Bogle
